Class I HDACs have been shown to be expressed at significantly higher levels in ovarian cancers in comparison with normal ovarian tissues, with no significant difference in Class II HDAC expression between the two groups (Khabele et al. 2007). The gene discussed is HDAC9; the disease is ovarian carcinoma.